John W. Poyhonen
Plus aucun poste en cours
Fortune : 129 215 $ au 31/03/2024
Profil
John W.
Poyhonen formerly worked at Senomyx, Inc., as President, Chief Executive Officer & Director from 2014 to 2018, Ardea Biosciences, Inc., as Independent Director from 2011 to 2012, Heron Therapeutics, Inc., as President & Chief Commercial Officer from 2020 to 2023, Agouron Pharmaceuticals LLC, as Vice President-National Sales in 2003, and Pfizer Inc., as Vice President-National Sales in 2003.
Mr. Poyhonen received his undergraduate degree in 1992 from Michigan State University and Masters Business Admin degree in 1982 from the University of Kansas.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HERON THERAPEUTICS INC
0,03% | 13/04/2023 | 46 648 ( 0,03% ) | 129 215 $ | 31/03/2024 |
Anciens postes connus de John W. Poyhonen
| Sociétés | Poste | Fin |
|---|---|---|
| HERON THERAPEUTICS, INC. | President | 30/04/2023 |
| SENOMYX INC. | Chief Executive Officer | 02/11/2018 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Director/Board Member | 01/06/2012 |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Sales & Marketing | 01/10/2003 |
| PFIZER, INC. | Sales & Marketing | 01/10/2003 |
Formation de John W. Poyhonen
| Michigan State University | Undergraduate Degree |
| University of Kansas | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Health Technology |
Senomyx, Inc.
 Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA. | Consumer Non-Durables |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Health Technology |
